LFCR DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCR

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Lifecore Biomedical, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on September 27, 2024 [1] Group 1: Class Action Details - Investors who purchased Lifecore securities between October 7, 2020, and March 19, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [3] - The lawsuit alleges that Lifecore made false and misleading statements regarding its financial reporting and internal controls, leading to inaccurate financial statements that would need to be restated [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4] - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been recognized as a leader in the field of securities class action litigation [4]